Cardiogenic Shock

Cardiology / Critical Care

Overview

Definition

A state of inadequate tissue perfusion due to cardiac dysfunction, resulting in severe hypotension and end-organ damage despite adequate intravascular volume.

Epidemiology

The leading cause of death in patients hospitalized with acute myocardial infarction. Very high mortality rate (40-50%).

Etiology & Risk Factors

  • Acute Myocardial Infarction (pump failure - most common)
  • Severe Valvular Disease (e.g., acute severe mitral regurgitation from papillary muscle rupture)
  • Arrhythmias (prolonged VT or extreme bradycardia)
  • Myocarditis / End-stage Cardiomyopathy

Clinical Symptoms

  • Severe hypotension (Systolic BP < 90 mmHg)
  • Cold, clammy, mottled extremities (poor perfusion)
  • Oliguria (decreased urine output)
  • Altered mental status / confusion
  • Tachycardia and tachypnea

Clinical Approach

Diagnosis

  • Echocardiogram (severely depressed LV/RV function, structural defects)
  • ECG (evaluate for STEMI/ischemia/arrhythmia)
  • Elevated Lactate (tissue hypoperfusion)
  • Pulmonary Artery (Swan-Ganz) Catheter (low cardiac index < 2.2, high pulmonary capillary wedge pressure > 15)

Management

  • Immediate revascularization (PCI/CABG) if caused by acute MI
  • Inotropes (Dobutamine, Milrinone) to increase cardiac contractility
  • Vasopressors (Norepinephrine) if severely hypotensive
  • Mechanical Circulatory Support (Intra-aortic balloon pump [IABP], Impella, ECMO) as a bridge to recovery or transplant
  • Diuretics (only once blood pressure is stabilized, to relieve congestion)

Complications

  • Multiple Organ Failure (Renal/Hepatic failure)
  • Lethal arrhythmias
  • Death